Healthcare
Japan Medical Dynamic Marketing, Inc.(JMDMF)
Live Price
Offline$5.00
+0.00% today
1Y Change
+49.70%
Window
Jun 26, 2025 โ Jun 16, 2026
- Market Cap
- $13.76B
- Revenue Growth
- 0.0%
- EPS Growth
- 0.0%
- Dividend Yield
- 3.3%
Coverage: 250 bars ยท Jun 26, 2025 โ Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Japan Medical Dynamic Marketing, Inc. (JMDMF) is a Healthcare stock with a market cap of $13.76B and listed on OTC. The stock last traded around $5.00 and up 49.7% across the available one-year price window (Jun 26, 2025 โ Jun 16, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 3.3%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin 3.4% and ROIC 2.6%. The dividend matters to the case here, with a current yield around 3.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.6. Stock Foundry combines JMDMF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
+3.4% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report was closer to in-line
2026 was reported on May 8, 2026 with revenue below estimates by -8.9%.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is 0.0%, while operating margin sits near 3.4%.
The next real check-in already has a date
The next earnings event is scheduled for Jul 24, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 8, 2026 | โ | +0.0% | +0.0% | +66.1% |
2026 Jan 30, 2026 | โ | +0.0% | +0.0% | +0.0% |
2025 Aug 1, 2025 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Edge
JMDMF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
JMDMF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
JMDMF Max Drawdown
-9.88%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for JMDMF and SPY.
Company Overview
Japan Medical Dynamic Marketing, Inc.
Other OTC
Japan Medical Dynamic Marketing, INC. develops, manufactures, imports, and sells medical devices in Japan and the United States. The company provides trauma devices, including nails, screws, plates, and other products surgically implanted in the fracture site; joint prostheses, which replaces natural joints and restores functions damaged or lost due to disease or injury; spinal fixation devices for the use in spinal instability surgery; and artificial bone fillers for the treatment of bone fractures, tumors, and other defects. It offers its products to medical professionals and hospitals. The company was incorporated in 1973 and is headquartered in Tokyo, Japan.
- Leadership
- Toshiyuki Hironaka
- IPO Date
- Mar 23, 2022
- Employees
- 511
- Street Address
- 12-2, Ichigayadaimachi
- Mailing
- Tokyo, 162-0066
- Region
- Tokyo, JP
- Reporting Currency
- USD
- Investor Line
- 81 3 3341 6705
- Last Updated
- May 1, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 23.2
- Price/Sales
- 0.6
- Price/Book
- 0.5
Growth
- Revenue
- 0.0%
- EPS
- 0.0%
- Free Cash Flow
- 0.0%
Profitability
- Gross Margin
- 54.3%
- Operating Margin
- 3.4%
- Net Margin
- -4.3%
- ROE
- -4.3%
- ROIC
- 2.6%
Balance Sheet
- Debt/Equity
- 0.22
- Current Ratio
- 3.68
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.